In this panel we get insights from leading medtech strategics J&J, Medtronic, Terumo, and Intuitive Surgical. We discuss the types of deals they are looking for and have each stakeholder weigh in on deal structure trends and provide a perspective on where they see M&A in 2020 and beyond.
We will also learn about an important global strategic partnership formed in 2019 between Terumo & Orchestra BioMed and how this innovative approach to risk/reward sharing for product development and commercialization might shape future deal-making opportunities for strategics and innovators.
Panelists include:
James Rushworth, CEO, Terumo
Nick Pachuda, WW Vice President, J&J
Julian Nikolchev, Senior VP Corporate Development & Strategy, Intuitive Surgical
David Hochman, CEO, Orchestra BioMedical
Earl Slee, VP of Technology, Strategy & Business Development, Medtronic
The panel is moderated by David Mildrew, Managing Partner, BioQuest.